Sangamo Therapeutics Inc at RBC Capital Markets Global Healthcare Conference Transcript
Yeah. Luca Issi, senior biotech analyst here at RBC Capital Market. And today is our great privilege to have Sangamo Therapeutics with us for a fireside chat. Representing the company, we have Sandy Macrae, Chief Executive Officer. Sandy, thanks so much for joining us. How are you doing today?
It's my pleasure, Luca. Great to be here.
Questions & Answers
Fantastic. We have a long list of questions here, but maybe before we talk about individual program, it will be great if you can just talk big picture about what progress has the organization made over the last few months, and most importantly, what's ahead of here for Sangamo?
So we're making great progress. Sangamo is a fascinating company. We have three things that are in late-phase development with our friends at Pfizer, where we're
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
